Hani Sabbour

1.3k total citations
44 papers, 329 citations indexed

About

Hani Sabbour is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Hani Sabbour has authored 44 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 16 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Surgery. Recurrent topics in Hani Sabbour's work include Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Hani Sabbour is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Hani Sabbour collaborates with scholars based in United Arab Emirates, United States and Saudi Arabia. Hani Sabbour's co-authors include Qammer H. Abbasi, Muhammad Ali Imran, Akram Alomainy, Ali Rizwan, Ahmed Zoha, Ameena Saad Al‐Sumaiti, Ismail Ben Mabrouk, Fatheya Alawadi, Alaaeldin Bashier and Elamin Abdelgadir and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Diabetes.

In The Last Decade

Hani Sabbour

35 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hani Sabbour United Arab Emirates	11	176	93	84	45	33	44	329
Chiara Di Pentima Italy	10	124 0.7×	65 0.7×	59 0.7×	44 1.0×	43 1.3×	26	323
Julie St. John United States	11	194 1.1×	262 2.8×	130 1.5×	23 0.5×	51 1.5×	24	461
Hanna B. Slim United States	5	64 0.4×	162 1.7×	37 0.4×	32 0.7×	59 1.8×	8	341
Scott Solomon United States	7	263 1.5×	77 0.8×	52 0.6×	69 1.5×	40 1.2×	40	425
Łukasz Januszkiewicz Poland	9	183 1.0×	133 1.4×	112 1.3×	11 0.2×	32 1.0×	22	337
Priyanka Kakar United States	9	145 0.8×	143 1.5×	101 1.2×	22 0.5×	33 1.0×	13	328
А. И. Ершова Russia	13	221 1.3×	188 2.0×	93 1.1×	42 0.9×	95 2.9×	98	487
Milan Pavlović Serbia	11	159 0.9×	65 0.7×	25 0.3×	38 0.8×	12 0.4×	55	306
Julie Pester United States	6	117 0.7×	32 0.3×	28 0.3×	44 1.0×	10 0.3×	8	260
Gunseog Kang South Korea	7	111 0.6×	90 1.0×	114 1.4×	48 1.1×	52 1.6×	17	379

Countries citing papers authored by Hani Sabbour

Since Specialization

Citations

This map shows the geographic impact of Hani Sabbour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hani Sabbour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hani Sabbour more than expected).

Fields of papers citing papers by Hani Sabbour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hani Sabbour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hani Sabbour. The network helps show where Hani Sabbour may publish in the future.

Co-authorship network of co-authors of Hani Sabbour

This figure shows the co-authorship network connecting the top 25 collaborators of Hani Sabbour. A scholar is included among the top collaborators of Hani Sabbour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hani Sabbour. Hani Sabbour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saleh, Khaled, et al.. (2025). Comparative efficacy and safety of prostacyclin therapies for pulmonary arterial hypertension: a systematic review and network meta-analysis. Frontiers in Medicine. 12. 1643220–1643220. 1 indexed citations

Manla, Yosef, Laila AbdelWareth, Hani Sabbour, et al.. (2025). Lipoprotein(a) testing and levels among patients with atherosclerotic cardiovascular disease: a large single-centre experience from the United Arab Emirates. European Journal of Preventive Cardiology.

Almahmeed, Wael, Fatheya Alawadi, Mostafa Q. Alshamiri, et al.. (2025). Improving Therapeutic Adherence and Reducing Therapeutic Inertia in the Management of People with Cardiometabolic Diseases: A Call-to-Action from the Middle East. Advances in Therapy. 42(3). 1340–1359. 1 indexed citations

Alawadi, Fatheya, Fouzia Rashid, Gil Awada, et al.. (2025). Prevalence of cardiovascular risk and atherosclerotic cardiovascular disease in people with type 2 diabetes in the United Arab Emirates: Results from the prevalence of atherosclerotic cardiovascular disease in patients with type 2 diabetes across Middle East and African countries (PACT-MEA) study. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 19(4). 103224–103224. 1 indexed citations

Bashier, Alaaeldin, et al.. (2025). Achievement of guideline targets among people with type 2 diabetes with eASCVD and high risk of ASCVD in the UAE: Results of the PACT-MEA-UAE cohort. Diabetes Research and Clinical Practice. 221. 112030–112030.

Sabbour, Hani, et al.. (2024). A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids. Cardiovascular Drugs and Therapy. 39(5). 1135–1151. 1 indexed citations

Sabbour, Hani, et al.. (2024). First Report of Inclisiran Utilization for Hypercholesterolemia Treatment in Real-world Clinical Settings in a Middle East Population. Clinical Therapeutics. 46(3). 186–193. 7 indexed citations

Ahmad, Aftab & Hani Sabbour. (2024). Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies. Cardiovascular Diabetology. 23(1). 99–99. 11 indexed citations

Verma, Subodh, Hani Sabbour, Naji Alamuddin, et al.. (2023). A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa ( PACT‐MEA ): Study design and rationale. Diabetes Obesity and Metabolism. 25(6). 1444–1452. 8 indexed citations

10.

Sabbour, Hani, et al.. (2023). Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies. Journal of Nuclear Cardiology. 30(5). 1922–1934. 4 indexed citations

11.

Ali, Tomader, et al.. (2023). Atherogenic Index of Plasma Associated Cardiovascular Risk in 10,241 Paediatric Patients. Endocrine Abstracts.

12.

Abdelhamid, Magdy, Bülent Altun, Mohammed Arafah, et al.. (2023). Regional Expert Opinion: Management of Heart Failure with Preserved Ejection Fraction in the Middle East, North Africa and Turkey. ESC Heart Failure. 10(5). 2773–2787. 2 indexed citations

13.

Shehab, Abdulla, et al.. (2022). Prevalence of Cardiovascular Risk Factors and 10-Years Risk for CoronaryHeart Disease in the United Arab Emirates. Current Diabetes Reviews. 19(3). e210422203892–e210422203892. 5 indexed citations

14.

Camm, A. John, Hani Sabbour, Oliver Schnell, Francesco Summaria, & Atul Verma. (2022). Managing thrombotic risk in patients with diabetes. Cardiovascular Diabetology. 21(1). 160–160. 13 indexed citations

15.

Sabbour, Hani, et al.. (2021). From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis. Frontiers in Cardiovascular Medicine. 8. 644508–644508. 12 indexed citations

16.

Bashier, Alaaeldin, et al.. (2019). Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases. Diabetology & Metabolic Syndrome. 11(1). 80–80. 40 indexed citations

17.

Hersi, Ahmad, et al.. (2017). Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa. Journal of the Saudi Heart Association. 30(2). 122–139. 8 indexed citations

18.

Al‐Rasadi, Khalid, Fatheya Alawadi, Saeed M G Al-Ghamdi, et al.. (2016). Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East. International Journal of Cardiology. 225. 268–283. 12 indexed citations

19.

Sabbour, Hani, et al.. (2013). Requirements for achieving and maintaining competency in the implantation and management of cardiac implantable electrical devices: A clinical competency statement by the Emirates Cardiac Society. SHILAP Revista de lepidopterología. 14(3). 97–97. 1 indexed citations

20.

Reddy, Vivek Y., Krit Jongnarangsin, Christine M. Albert, et al.. (2003). Para‐Hisian Entrainment: A Novel Pacing Maneuver to Differentiate Orthodromic Atrioventricular Reentrant Tachycardia from Atrioventricular Nodal Reentrant Tachycardia. Journal of Cardiovascular Electrophysiology. 14(12). 1321–1328. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact